Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vibhavadi Medical Center PCLBKK:VIBHA 70 5-Year Yield-on-Cost % is 5.31 as of Aug. 04, 2026, which is 115% above its 10-year median of 2.47. GuruFocus rates BKK:VIBHA with a GF Score™ of 70/100 and a GF Value™ of ฿1.75 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Vibhavadi Medical Center PCL ranks better than 75.36% on this metric.
The historical rank and industry rank for Vibhavadi Medical Center PCL's 5-Year Yield-on-Cost % or its related term are showing as below:
BKK:VIBHA'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.24 Med: 2.47 Max: 5.43
Current: 5.31
During the past 13 years, Vibhavadi Medical Center PCL's highest Yield on Cost was 5.43. The lowest was 1.24. And the median was 2.47.
BKK:VIBHA's 5-Year Yield-on-Cost % is ranked better than 75.36% of 276
companies
in the Healthcare Providers & Services industry
Industry Median: 2.985
vs BKK:VIBHA: 5.31
Vibhavadi Medical Center PCL (BKK:VIBHA) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Vibhavadi Medical Center PCL 5-Year Yield-on-Cost % Related Terms
BKK:VIBHA vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Vibhavadi Medical Center PCL's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vibhavadi Medical Center PCL 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Vibhavadi Medical Center PCL's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Vibhavadi Medical Center PCL's 5-Year Yield-on-Cost % falls into.
Vibhavadi Medical Center PCL 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Vibhavadi Medical Center PCL (BKK:VIBHA) has a 5-Year Yield-on-Cost % of 5.31 as of Aug. 04, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Vibhavadi Medical Center PCL and its competitors. This is 115% above median its historical median of 2.47. Over the past decade, Vibhavadi Medical Center PCL's 5-Year Yield-on-Cost % has ranged from 1.24 to 5.43. According to the industry distribution chart, Vibhavadi Medical Center PCL ranks #68 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 24.6%.
Is Vibhavadi Medical Center PCL's 5-Year Yield-on-Cost % too high?
Vibhavadi Medical Center PCL's current 5-Year Yield-on-Cost % of 5.31 is 115% above median its 10-year median of 2.47. Over the past 10 years, this metric has ranged from a low of 1.24 to a high of 5.43. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.99. Vibhavadi Medical Center PCL's value of 5.31 is 77.9% above this industry median. Based on the distribution chart, Vibhavadi Medical Center PCL ranks #68 out of 276 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Vibhavadi Medical Center PCL has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vibhavadi Medical Center PCL's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Vibhavadi Medical Center PCL ranks #68 out of 276 companies for 5-Year Yield-on-Cost %. This places Vibhavadi Medical Center PCL in the top 25% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.99. Vibhavadi Medical Center PCL's value of 5.31 is 77.9% above this benchmark. Historically, Vibhavadi Medical Center PCL's own 5-Year Yield-on-Cost % has ranged from 1.24 to 5.43 over the past decade. While the company's 10-year median is 2.47 vs. the industry median of 2.99, Vibhavadi Medical Center PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.99, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vibhavadi Medical Center PCL's current 5-Year Yield-on-Cost % of 5.31 is 77.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Vibhavadi Medical Center PCL and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vibhavadi Medical Center PCL's current 5-Year Yield-on-Cost % is 5.31, which is 115% above median its own 10-year median of 2.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibhavadi Medical Center PCL stock overvalued right now?
Based on GuruFocus' analysis, Vibhavadi Medical Center PCL (BKK:VIBHA) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.75, compared to a current price of ฿1.36 — trading 22.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 5.31, which is 115% above median its 10-year median of 2.47 and 77.9% above the Healthcare Providers & Services industry median of 2.99. Vibhavadi Medical Center PCL's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Vibhavadi Medical Center PCL (BKK:VIBHA), the current 5-Year Yield-on-Cost % is 5.31 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vibhavadi Medical Center PCL (BKK:VIBHA) Overvalued in 2026?
Based on GuruFocus' analysis, Vibhavadi Medical Center PCL stock appears to be undervalued.
The current stock price of ฿1.36 is trading 22.3% below its estimated GF Value™ of ฿1.75.
GuruFocus considers Vibhavadi Medical Center PCL to be Modestly Undervalued.
Key valuation signals for BKK:VIBHA:
5-Year Yield-on-Cost %: 5.31 (115% above median its 10-year median of 2.47)
GF Value™: ฿1.75 vs. price of ฿1.36 (22.3% below fair value)
Industry Position: 77.9% above the Healthcare Providers & Services median (#68 of 276)
No single metric tells the full story. See the BKK:VIBHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vibhavadi Medical Center PCL provides the medical services known as Vibhavadi Hospital. The services provided include Pediatric Diseases, General Surgery, Orthopedic Center, General Medicine, Women's Health, Gastrointestinal Center, Cardiology, Neurology, Brain Tumor Surgery, Gamma Knife Radiosurgery for Brain, Cancer, Respiratory Diseases, Plastic Surgery, ENT (Ear, Nose, Throat) Department, Dental Center, Life Style Health Screening Center, Lasik Center, Eye, Hemodialysis Department, Dermatology Center, and Other Clinics and Services. Its segments include Hospital provides general hospital and hospital in social security; and Others provide rental services and rental space. The majority of the revenue is derived from the Hospital segment.
70GF Score
Get the complete analysis for BKK:VIBHA
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:VIBHA has been successfully added to your 
